Skip to main content
. 2018 Feb 8;13(2):e0192529. doi: 10.1371/journal.pone.0192529

Table 2. Multivariable adjusted comparisons of opioid exposure prevalence.

  Opioid
Prevalence, %
Opioid Prevalence Ratio
(95% confidence interval)
Non-opioid
Prevalence, %
Non-opioid Prevalence Ratio
(95% confidence interval)
Gender
Female 81.3 0.99 (0.96, 1.01) 84.8 1.01 (0.99, 1.03)
  Male 82.2 Reference 84.7 Reference
Age, years
<1 78.2 1.06 (0.99, 1.14) 82.7 1.02 (0.96, 1.08)
1 to < 5 73.8 Reference 79.0 Reference
5 to <10 78.1 1.06 (0.99, 1.12) 86.5 1.07 (1.02, 1.13)*
10 to <15 87.2 1.18 (1.11, 1.26)* 87.7 1.11 (1.05, 1.18)*
  15 to <20 92.9 1.26 (1.18, 1.34)* 88.4 1.12 (1.04, 1.20)*
Race
White 79.8 Reference 85.3 Reference
Black 81.9 1.03 (0.98, 1.08) 80.7 1.00 (0.96, 1.04)
Asian 82.6 1.03 (0.93, 1.16) 93.2 1.06 (1.00, 1.11)
  Other 82.6 1.03 (0.99, 1.08) 83.5 1.02 (0.94, 1.11)
Insurance
Private 80.9 Reference 84.6 Reference
Public 82.2 1.01 (0.98, 1.05) 82.8 1.00 (0.96, 1.03)
  Other 82.1 1.01 (0.96, 1.07) 90.1 1.04 (0.98, 1.12)
Total Parenteral Nutrition
Yes 88.1 1.16 (1.13, 1.20)* 88.4 1.06 (1.01, 1.11)*
  No 75.8 Reference 83.6 Reference
ICU level care
Yes 85.9 1.10 (1.07, 1.14)* 92.1 1.04 (1.00, 1.09)
  No 77.8 Reference 83.9 Reference

*p-value <0.05

All models adjusted for presented covariates, chemotherapy course and diagnosis year.